Tianyu Yu
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes 6
- Renal Diseases and Glomerulopathies 3
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
-
- Gastric Cancer Management and Outcomes 3
- Ferroptosis and cancer prognosis 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Pancreatic function and diabetes 3
In The Last Decade
Tianyu Yu
29 papers receiving 485 citations
Peers
Comparison fields: 5 of 101
- Nephrology 79
- Immunology 81
- Molecular Medicine 18
- Clinical Biochemistry 22
- Gastroenterology 17
Countries citing papers authored by Tianyu Yu
This map shows the geographic impact of Tianyu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyu Yu more than expected).
Fields of papers citing papers by Tianyu Yu
This network shows the impact of papers produced by Tianyu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyu Yu. The network helps show where Tianyu Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tianyu Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 18 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 44 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 48 | |
| 13 | 2019 | 11 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 40 | |
| 16 | 2019 | 13 | |
| 17 | 2019 | 4 | |
| 18 | 2019 | 19 | |
| 19 | 2018 | 1 | |
| 20 | 2018 | 43 |
About Tianyu Yu
Tianyu Yu is a scholar working on Nephrology, Gastroenterology and Cardiology and Cardiovascular Medicine, having authored 31 papers that have together received 490 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (6 papers), RNA modifications and cancer (4 papers), Renal Diseases and Glomerulopathies (3 papers), Gastric Cancer Management and Outcomes (3 papers), Epigenetics and DNA Methylation (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Pancreatic function and diabetes (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Nephrology (79 citations), Immunology (81 citations) and Molecular Medicine (18 citations). Tianyu Yu has collaborated with scholars based in China, Singapore and Germany. Frequent co-authors include Wenge Li, Shimin Jiang, Yaguang Li, Feiyu Shi, Guming Zou, Guanghui Wang, Hongmei Gao, Chengxin Shi, Bing Xu and Lihong Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.